When it comes to drug development and manufacturing, operational excellence (OpEx) is critical for success at all levels. It can help establish a culture of continuous improvement and innovation while supporting data quality, compliance, customer satisfaction, and more. It can even impact external perceptions of the company and confidence in the strength of the business.…

As 2023 draws to a close, the pharma industry finds itself at an inflection point. On the one hand, stubbornly high inflation rates, a dearth of talent, supply chain hurdles, and a more challenging regulatory climate threaten profitability. But on the other, the rapid advances in areas ranging from cell and gene therapy and IT…

Heading into 2024, the pharma industry finds itself in uncharted waters. On the one hand, the sector’s commitment to R&D investment and innovation output is likely to remain strong, with tools based on AI, automation and real-world data promising more streamlined drug candidate optimization. Additionally, the pharma sector is typically resilient in economic downturns. Financial…

With the rise of biologics and personalized medicine, the biopharmaceutical industry is adding single-use technologies (SUTs) to their manufacturing options. Manufacturers are realizing the benefits of being agile, and many are adopting SUTs to turn over smaller batches of new products quickly and efficiently. Single-use technologies use disposable bioprocessing equipment, such as bags and flexible…

Digitalization empowers pharmaceutical companies to bring therapies to patients faster by using advanced analytics strategies to profitably optimize manufacturing operations. In the pharmaceutical industry, operational issues from efficiency losses to failed batches can delay delivery of potentially lifesaving therapies to patients. For this and other reasons, pharmaceutical organizations require resources dedicated to batch prediction, planning…

Single-use instrumentation, especially new pH sensors designed for upstream and downstream applications, are helping manufacturers develop production suites for creating a greater variety of small-run yet highly targeted drugs. Life sciences manufacturers already incorporate leading measurement and automation technologies to ensure the quality of the drugs and medicines they bring to market. Yet because the…

Pharma companies are ramping up their reliance on AI in drug discovery, clinical trials and manufacturing. Bloomberg recently frame the technology as providing a $50 billion opportunity to the sector. GlobalData noted that the pandemic played a role in stoking interest in AI. But given the hype often surrounding the technology, it can be difficult…

The magnitude of climate change looms larger by the day. A 2022 report from Deloitte Center for Sustainable Progress (DCSP) concluded that the price tag of unchecked climate change could ultimately reach $178 trillion over the next half-century. Although the pharma sector sometimes evades the spotlight when it comes to sustainability, it accounts for 4.4%…

Preventing sudden failures and unexpected downtime in life sciences organizations starts with promoting a data-driven culture across the enterprise. Promoting a data-driven culture across the enterprise is what makes today’s most successful life sciences organizations stand out. Efficient operations are only possible when the processes underlying those activities are functional, and this type of reliable…

The life sciences and food and beverage consulting firm CRB has named Mike Dieterich as its senior director of sustainability. Dieterich has more than 17 years of experience working in energy and sustainability. He’s led sustainability initiatives at companies such as AstraZeneca where he served as director, U.S. sustainability from January 2018 to April 2023.…